Guidance for Procurement

Advice to Chief Pharmacists from the NHS Pharmaceutical Quality Assurance Committee

 

(For assessing the quality of Cannabis-Based Products for Medicinal Use (CBPM) and cannabis-based food supplements).

Preview

 

 

Overview

 

 The document provides an overview of the quality assurance issues to consider when procuring and supplying cannabis products for medicinal use.

 

With the exception of Sativex, cannabis-based products available in the UK fall into 3 categories

 

1. Unlicensed cannabis-based products for medicinal use (CBPM)

 

2. (Licensed) cannabidiol (CBD)-only medicinal products. Epidyolex is currently the only product in this category

 

3. Cannabis-based products marketed as food supplements

 

Specific guidance about the quality of unlicensed cannabis-based products for medicinal use in humans is set out in MHRA Guidance which can be found here.